Robert B. Hance, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 106,897 shares at $56.74 ($6.1M) on 2012-02-29, disclosed to the SEC on 2012-03-02.
Scheduled sale ($6.1M) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.70 | 373 | $21K | 0.3% |
| 2 | $56.70 | 6,300 | $357K | 5.9% |
| 3 | $56.71 | 18,100 | $1.0M | 16.9% |
| 4 | $56.71 | 227 | $13K | 0.2% |
| 5 | $56.71 | 5,873 | $333K | 5.5% |
| 6 | $56.71 | 100 |
| $6K |
| 0.1% |
| 7 | $56.72 | 400 | $23K | 0.4% |
| 8 | $56.72 | 4,112 | $233K | 3.8% |
| 9 | $56.73 | 6,550 | $372K | 6.1% |
| 10 | $56.73 | 900 | $51K | 0.8% |
| 11 | $56.74 | 8,600 | $488K | 8.0% |
| 12 | $56.74 | 7,450 | $423K | 7.0% |
| 13 | $56.75 | 6,500 | $369K | 6.1% |
| 14 | $56.75 | 100 | $6K | 0.1% |
| 15 | $56.75 | 400 | $23K | 0.4% |
| 16 | $56.75 | 7,627 | $433K | 7.1% |
| 17 | $56.76 | 200 | $11K | 0.2% |
| 18 | $56.76 | 6,176 | $351K | 5.8% |
| 19 | $56.77 | 5,100 | $290K | 4.8% |
| 20 | $56.77 | 9,900 | $562K | 9.3% |
| 21 | $57.04 | 10,133 | $578K | 9.5% |
| 22 | $57.04 | 1,776 | $101K | 1.7% |
| Total | $56.77 avg | 106,897 | $6.1M | 100% |
| Filing → |
| ABT | SELL | 2011-12-16 | $4.2M | — | Filing → |
| ABT | SELL | 2011-03-02 | $75K | — | Filing → |
| ABT | SELL | 2011-02-10 | $2.4M | — | Filing → |